Pancreatic Cancer Research

ResearcherUniversity of Maryland, BaltimoreNo recent work listed

Jason K. Molitoris

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8221-1631; OpenAlex author ID A5021553632. Sources: ClinicalTrials.gov.

Their work

Papers
2 (first author 1, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 trial

Papers 2

  1. Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment response. Co-author DOI 10.3389/fonc.2022.1072774↗
  2. The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings. First author DOI 10.1016/j.soc.2017.01.012↗

Trials 1

  1. Hyperthermia Treatment Added to Chemotherapy Standard of Care for Pancreatic Tumors Principal investigator NCT05959395↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pierre N Floriano · 1 shared trial, 2023 · strength 0.58
  2. William F. Regine · 2 shared papers, 2017–2022 · strength 0.23
  3. J Polf · 1 shared paper, 2022 · strength 0.14
  4. Hem Dutt Shukla · 1 shared paper, 2022 · strength 0.14
  5. Michael David Chuong · 1 shared paper, 2017 · strength 0.09
  6. Adeel Kaiser · 1 shared paper, 2017 · strength 0.09
  7. Shahed Nicolas Badiyan · 1 shared paper, 2017 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.